Cellectar Biosciences, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cellectar Biosciences, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Cellectar Biosciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 25, 2024 was 40.6M shares, a 230% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 40.6M +28.3M +230% Oct 25, 2024 10-Q 2024-10-29
Q1 2024 32.3M +22.5M +231% Mar 21, 2024 10-K/A 2024-10-29
Q3 2023 12.3M +2.9M +30.9% Nov 10, 2023 10-Q 2023-11-13
Q2 2023 9.74M +3.63M +59.4% Aug 9, 2023 10-Q 2023-08-14
Q1 2023 9.74M -51.4M -84.1% Mar 3, 2023 10-K/A 2023-03-16
Q3 2022 9.39M -51.7M -84.6% Oct 31, 2022 10-Q 2022-11-03
Q2 2022 6.11M -55M -90% Aug 2, 2022 10-Q 2022-08-05
Q1 2022 61.1M +10.6M +21% Mar 18, 2022 10-K 2022-03-21
Q3 2021 61.1M +34.3M +128% Nov 5, 2021 10-Q 2021-11-08
Q2 2021 61.1M +34.5M +129% Aug 4, 2021 10-Q 2021-08-09
Q1 2021 50.5M +41.1M +438% Mar 1, 2021 10-K 2021-03-02
Q3 2020 26.8M +17.4M +185% Nov 4, 2020 10-Q 2020-11-09
Q2 2020 26.6M +17.2M +183% Aug 6, 2020 10-Q 2020-08-10
Q1 2020 9.4M +4.08M +76.8% May 4, 2020 10-Q 2020-05-07
Q3 2019 9.4M +4.64M +97.5% Nov 7, 2019 10-Q 2019-11-12
Q2 2019 9.4M +5.8M +161% Aug 5, 2019 10-Q 2019-08-12
Q1 2019 5.32M -12.1M -69.4% May 1, 2019 10-Q 2019-05-06
Q3 2018 4.76M -11.1M -69.9% Nov 9, 2018 10-Q 2018-11-13
Q2 2018 3.6M -10.3M -74.2% Aug 8, 2018 10-Q 2018-08-10
Q1 2018 17.4M +4.55M +35.4% Mar 15, 2018 10-K 2018-03-21
Q3 2017 15.8M +10.4M +195% Nov 9, 2017 10-Q 2017-11-09
Q2 2017 13.9M +8.55M +159% Aug 9, 2017 10-Q 2017-08-14
Q1 2017 12.8M +12M +1396% Mar 10, 2017 10-K 2017-03-15
Q3 2016 5.37M -3.21M -37.4% Oct 14, 2016 10-K/A 2016-10-20
Q2 2016 5.37M -2.2M -29% Aug 8, 2016 10-Q 2016-08-11
Q1 2016 858K -6.7M -88.7% Mar 7, 2016 10-K 2016-03-11
Q3 2015 8.58M +1.02M +13.5% Nov 9, 2015 10-Q 2015-11-12
Q2 2015 7.56M +4.69M +164% Aug 7, 2015 10-Q 2015-08-12
Q1 2015 7.56M -49.8M -86.8% Mar 20, 2015 10-K/A 2015-05-20
Q3 2014 7.56M -49.8M -86.8% Nov 10, 2014 10-Q/A 2015-05-20
Q2 2014 2.87M -54.5M -95% Aug 1, 2014 10-Q 2014-08-04
Q1 2014 57.4M 0 0% Mar 14, 2014 10-K 2014-03-19
Q3 2013 57.4M +11M +23.7% Nov 12, 2013 10-Q 2013-11-13
Q2 2013 57.4M +14.2M +32.8% Aug 9, 2013 10-Q 2013-08-12
Q1 2013 57.4M +20.5M +55.5% Mar 25, 2013 10-K 2013-03-28
Q3 2012 46.4M +19.6M +73% Nov 2, 2012 10-Q 2012-11-06
Q2 2012 43.2M +16.4M +61.2% Aug 7, 2012 10-Q 2012-08-09
Q1 2012 36.9M Mar 2, 2012 10-K 2012-03-09
Q3 2011 26.8M Nov 4, 2011 10-Q 2011-11-07
Q2 2011 26.8M Aug 10, 2011 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.